期刊文献+

养阴清肺方结合化疗治疗小细胞肺癌20例临床观察 被引量:6

Clinical Observation on 20 Cases of Small Cell Carcinoma of Lung Treated by Yangyin Qingfei Decoction Combined with Chemotherapy
暂未订购
导出
摘要 目的 :评估养阴清肺方协同化疗治疗中晚期小细胞肺癌的近期疗效。方法 :39例中晚期SCLC随机分成治疗组和对照组 ,采用NP方案化疗 ,治疗组化疗同时服用养阴清肺方 ,对照组单纯用NP方案化疗。结果 :治疗组总有效率 (CR +PR)为 70 % ,对照组总有效率 (CR +PR)为 70 % ,对照组总有效率 (CR +PR)为 4 7.36 % ,两组相比差异具有显著性 (P <0 .0 5 )。治疗组毒副反应比对照组明显减轻 (P <0 .0 5 )。结论 :养阴清肺方协同NP方案化疗治疗中晚期SCLC近期疗效较为满意 。 Objective:To evalute the near curative effects of Yangyin Qingfei decoction combined with chemotherapy on intermediate and late small cell carcimoma of lung.Method:39 cases of intermediate and late SCLC were randomly divided into treatment group and control group,the treatment group was treated by NP plan themo therapy combined with Yangyin Qingfei decoction,the control group was treated simply with NP plan chemotherapy.Results:The total effective rate was 70% in the treatment group and 47.36% in the control group( P<0.05 ),the toxic and side reaction were decresed obviously in the treatment group as compared with the control group( P<0.05 ).Conclusion:Yangyin Qingfei decoction combined with Np plan chemotheray has satisfied near therapeatic effect on intermediate and late SCLC with a little toxic and side reaction.
出处 《湖南中医杂志》 2002年第6期4-5,共2页 Hunan Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献7

  • 1[1]Lichtman S, Ratain M,Budman D, et al. Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) plus high-dose cyclophosphamide (CYC) in solid tumors[J]. Porc Am Soc Clin Oncol,1990,9:66.Abstract.
  • 2[2]Gianni AM, Bregni M, Siena S, et al. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients[J]. J Clin Oncol,1992,10:1955
  • 3[3]Fetscher T, Brugge W, Engelhardt R, et al. Standard-and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report[J]. Ann Oncol,1999,10(5):561
  • 4[4]Brigger W, Fetscher S, Hasse J, et al. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer[J]. Semin Oncol,1998,25(Suppl A):42
  • 5[5]Takahashi M, Yoshizawa H, Tanaka H, et al. Phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer[J]. Bone Marrow Transplantation,2000,25:5
  • 6[6]Korbling M, Flidner TM,Holle R, et al. Autologous blood stem cell versus purged bone marrow transplantation in standard risk AML:influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival[J]. Bone Marrow Transplant,1991,7:343
  • 7[7]Leyvras S, Perey L, Rosti G, et al. Mutiple courses of high-dose ifosfamide, carboplatin, and etopside with peripheral-blood progenitor cell and filgrastim for small-cell lung caner:A feasibility by the European Group for blood and marrow transplantation[J].J Clin Oncol,1999,17(11):3531

共引文献1

同被引文献88

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部